Tickers

1. Composite Trajectory Verdict

Given JBTM's business as a capital-intensive food and beverage technology provider with a significant recurring revenue base (~50% of revenue), the cash flow statement carries the most weight for assessing ongoing financial performance because it reflects the conversion of backlog and recurring streams into liquidity after working capital and capital expenditure needs.

Composite Trajectory: Mixed

The earnings trajectory shows a sharp GAAP deterioration in 2025 (net loss of $50.5M vs. $85.4M income in 2024) driven by one-time pension settlement charges, higher interest expense, and acquisition-related costs, even as operating income rose 60% to $189.4M on acquisition-driven revenue growth (10-K 2025, Consolidated Statements of Operations). Cash generation improved steadily, with operating cash flow rising to $341.7M in 2025 from $232.6M in 2024 and $74.2M in 2023, and free cash flow increasing to $249.8M from $199.3M (10-K 2025, Consolidated Statements of Cash Flows; Reconciliation of Non-GAAP Measures). The balance sheet reflects a mixed picture: equity doubled to $4.46B via share issuance for the Marel acquisition, but net debt swung from a net cash position to approximately $1.7B, the current ratio fell below 1.0x, and goodwill plus intangibles grew to 68% of total assets (10-K 2025, Consolidated Balance Sheets; Note 8). Quarterly data for 2026 is insufficient to alter this annual assessment.

2. Red Flags

• GAAP net income swung to a $50.5M loss in 2025 from $85.4M income in 2024, primarily due to a $146.9M pension settlement charge, a $95M increase in interest expense, $29.3M restructuring expense, and a $10.6M loss on investment (10-K 2025, Consolidated Statements of Operations).
• Gross profit margin compressed 140 bps to 35.1% in 2025 despite a 121% revenue increase, attributed to tariff impacts and project inefficiencies in Prepared Food and Beverage Solutions (10-K 2025, MD&A).
• Net debt increased dramatically: cash fell from $1.23B to $167.9M while total debt rose from $1.25B to $1.88B, resulting in a net debt position of ~$1.7B versus net cash a year prior (10-K 2025, Consolidated Balance Sheets; Note 8).
• Current ratio deteriorated to 0.98x (current assets $1.58B vs. current liabilities $1.62B) at December 31, 2025 from 3.48x at December 31, 2024 (10-K 2025, Consolidated Balance Sheets).
• Goodwill and intangible assets ballooned to $5.55B (68% of total assets) at year-end 2025 from $1.11B at year-end 2024, creating significant impairment sensitivity (10-K 2025, Consolidated Balance Sheets; Note 7).
• Restructuring cost estimates for the JBT Marel 2025 Integration plan were raised twice during 2025, from $25–30M to $30–35M and finally to $55–60M, with $31.2M recognized through year-end and the remainder expected in 2026 (10-K 2025, Note 21).
• Inbound orders on a constant-currency basis excluding the acquisition decreased $130M year-over-year in 2025 (10-K 2025, MD&A – Inbound Orders and Order Backlog).
• Non-GAAP adjusted EBITDA margin declined 140 bps to 15.8% in 2025 from 17.2% in 2024, with the company attributing the drop to lower gross margin and higher SG&A percentage from the acquired Marel business (10-K 2025, MD&A; Reconciliation of Non-GAAP Measures).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Revenue grew 121.3% to $3.80B in 2025 from $1.72B in 2024, almost entirely from the Marel acquisition ($1.97B incremental revenue) with only $39.8M organic growth (10-K 2025, MD&A). Operating income increased 60% to $189.4M, but GAAP loss from continuing operations widened to $49.7M from $84.6M income due to a $146.9M pension settlement charge, $95M higher interest expense, $29.3M restructuring, and a $10.6M investment loss (10-K 2025, Consolidated Statements of Operations). Gross margin fell 140 bps to 35.1% (10-K 2025, Consolidated Statements of Operations). Adjusted EBITDA (non-GAAP) rose 103.5% to $600.4M, though its margin declined 140 bps to 15.8% (10-K 2025, Reconciliation of Non-GAAP Measures). The pre-acquisition trend (2023–2024) showed revenue growth of 3.1% but operating income declining 28% and continuing operations income falling 35% (10-K 2025, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Overall Assessment: Cash provided by continuing operating activities increased each year: $341.7M in 2025, $232.6M in 2024, and $74.2M in 2023 (10-K 2025, Consolidated Statements of Cash Flows). Free cash flow (non-GAAP) also rose steadily: $249.8M in 2025, $199.3M in 2024, and $166.5M in 2023 (10-K 2025, Reconciliation of Non-GAAP Measures). The 2025 operating cash flow improvement was driven by higher non-cash charges (depreciation, amortization, pension expense, inventory step-up amortization) partially offset by working capital increases from the acquired Marel business (10-K 2025, MD&A – Cash Flows). Investing cash flow in 2025 was dominated by the $1.75B Marel acquisition outflow (10-K 2025, Consolidated Statements of Cash Flows). Financing cash flow provided $458.1M in 2025 from Term Loan B proceeds ($896.9M) and convertible notes ($559.4M), partly offset by revolving credit facility repayments ($2.38B) (10-K 2025, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets more than doubled to $8.19B at December 31, 2025 from $3.41B at December 31, 2024, driven by $2.32B of goodwill and $1.78B of intangible assets from the Marel acquisition (10-K 2025, Consolidated Balance Sheets; Note 7). Total debt increased to $1.88B from $1.25B, while cash dropped to $167.9M from $1.23B, shifting from a net cash to a ~$1.7B net debt position (10-K 2025, Consolidated Balance Sheets; Note 8). Stockholders' equity nearly tripled to $4.46B from $1.54B due to the issuance of 19.98M shares for the acquisition (10-K 2025, Consolidated Statements of Changes in Stockholders’ Equity). The current ratio fell to 0.98x from 3.48x as current liabilities surged to $1.62B (including $412M short-term debt and $518M advance payments) while current assets grew modestly to $1.58B (10-K 2025, Consolidated Balance Sheets). By June 30, 2026, cash further declined to $93M, short-term debt fell to $9M, long-term debt rose to $1.67B, and current liabilities decreased to $1.30B, improving the current ratio to ~1.24x (10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

• Quarterly GAAP income statements and cash flow statements for Q1 2026, Q2 2026, Q3 2025, and Q2 2025 are not provided in the filings excerpt, preventing quarterly trend analysis.
• Organic revenue growth rates for 2026 quarters (to assess post-acquisition underlying performance).
• Segment-level GAAP operating income for quarterly periods.
• Detailed debt maturity schedule beyond the contractual obligations summary in the 10-K.
• Quarterly free cash flow and capital expenditure data for 2026.
• Pro forma full-year 2025 organic revenue growth excluding acquisition (only $39.8M mentioned in MD&A).
• Quarterly inbound orders and backlog data for 2026.
• Goodwill impairment testing details for the new reporting units post-realignment (only qualitative assessment results disclosed).